SheerVision, Inc. (SVSO)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2009 | 2.33 Million USD | -20.29% |
| 2008 | 2.92 Million USD | -23.63% |
| 2007 | 3.82 Million USD | 23.25% |
| 2006 | 3.1 Million USD | 4703.23% |
| 2005 | 64.69 Thousand USD | -21.94% |
| 2004 | 82.87 Thousand USD | -11.35% |
| 2003 | 93.49 Thousand USD | 166.11% |
| 2002 | 35.13 Thousand USD | 104.11% |
| 2001 | 17.21 Thousand USD | 34.92% |
| 2000 | 12.75 Thousand USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2010 Q1 | 474.53 Thousand USD | 11.18% |
| 2010 Q3 | 626.68 Thousand USD | 3.18% |
| 2010 Q2 | 607.37 Thousand USD | 27.99% |
| 2009 Q3 | 617.26 Thousand USD | -5.22% |
| 2009 Q1 | 636.3 Thousand USD | -8.6% |
| 2009 Q4 | 426.82 Thousand USD | -30.85% |
| 2009 Q2 | 651.24 Thousand USD | 2.35% |
| 2009 FY | 2.33 Million USD | -20.29% |
| 2008 Q3 | 843.43 Thousand USD | 27.76% |
| 2008 Q4 | 696.18 Thousand USD | -17.46% |
| 2008 FY | 2.92 Million USD | -23.63% |
| 2008 Q1 | 725.17 Thousand USD | 3.33% |
| 2008 Q2 | 660.19 Thousand USD | -8.96% |
| 2007 Q3 | 952.63 Thousand USD | -4.44% |
| 2007 Q2 | 996.9 Thousand USD | -15.42% |
| 2007 Q1 | 1.17 Million USD | 23.69% |
| 2007 FY | 3.82 Million USD | 23.25% |
| 2007 Q4 | 701.78 Thousand USD | -26.33% |
| 2006 Q1 | 5702.00 USD | -20.55% |
| 2006 Q2 | 768.21 Thousand USD | 13372.76% |
| 2006 Q3 | 831.26 Thousand USD | 8.21% |
| 2006 FY | 3.1 Million USD | 4703.23% |
| 2006 Q4 | 952.87 Thousand USD | 14.63% |
| 2005 FY | 64.69 Thousand USD | -21.94% |
| 2005 Q1 | 22.31 Thousand USD | 27.77% |
| 2005 Q3 | 8213.00 USD | -50.82% |
| 2005 Q2 | 16.7 Thousand USD | -25.17% |
| 2005 Q4 | 7177.00 USD | -12.61% |
| 2004 Q4 | 17.46 Thousand USD | -40.23% |
| 2004 Q1 | 18.22 Thousand USD | 6.3% |
| 2004 Q2 | 18.29 Thousand USD | 0.38% |
| 2004 FY | 82.87 Thousand USD | -11.35% |
| 2004 Q3 | 29.22 Thousand USD | 59.78% |
| 2003 FY | 93.49 Thousand USD | 166.11% |
| 2003 Q4 | 17.14 Thousand USD | -5.63% |
| 2003 Q3 | 18.16 Thousand USD | -26.71% |
| 2003 Q2 | 24.78 Thousand USD | 514.55% |
| 2003 Q1 | 4033.00 USD | -84.92% |
| 2002 Q2 | 7471.00 USD | 85.25% |
| 2002 Q4 | 26.74 Thousand USD | 148.49% |
| 2002 FY | 35.13 Thousand USD | 104.11% |
| 2002 Q1 | 4033.00 USD | -68.65% |
| 2002 Q3 | 10.76 Thousand USD | 44.08% |
| 2001 Q4 | 12.86 Thousand USD | 94.17% |
| 2001 Q3 | 6625.00 USD | 87.68% |
| 2001 Q2 | 3530.00 USD | -26.14% |
| 2001 Q1 | 4779.00 USD | 109.88% |
| 2001 FY | 17.21 Thousand USD | 34.92% |
| 2000 Q3 | 8784.00 USD | 521.22% |
| 2000 Q4 | 2277.00 USD | -74.08% |
| 2000 Q1 | 1259.00 USD | -3.15% |
| 2000 FY | 12.75 Thousand USD | 0.0% |
| 2000 Q2 | 1414.00 USD | 12.31% |
| 1999 Q4 | 1300.00 USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| American Medical Technologies Inc. | 2.86 Million USD | 18.569% |
| Ansell Limited | 495.5 Million USD | 99.529% |
| Ansell Limited | 495.5 Million USD | 99.529% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 82.8 Million USD | 97.184% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 1.73 Million USD | -34.718% |
| Psykey, Inc. | 1.21 Million USD | -92.144% |
| ConvaTec Group Plc | 910.31 Million USD | 99.744% |
| ConvaTec Group Plc | 872.5 Million USD | 99.733% |
| Encision Inc. | 3.77 Million USD | 38.263% |
| Golden Valley Development, Inc | 141.81 Thousand USD | -1544.185% |
| Hear AtLast Holdings, Inc. | 109.93 Thousand USD | -2020.999% |
| Innovative MedTech Inc. | 6.09 Million USD | 61.77% |
| LifePoint, Inc. | 7.42 Million USD | 68.593% |
| Medite Cancer Diagnostics, Inc. | 6.34 Million USD | 63.276% |
| Paradigm Medical Industries, Inc. | 855 Thousand USD | -172.706% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 726.13 Thousand USD | -221.103% |
| Reflect Scientific, Inc. | 1.06 Million USD | -119.201% |
| SmileDirectClub, Inc. | 517 Million USD | 99.549% |
| Sector 10, Inc. | 39.84 Thousand USD | -5751.91% |
| Shandong Weigao Group Medical Polymer Company Limited | 6.64 Billion USD | 99.965% |
| United Health Products, Inc. | 2.42 Million USD | 3.911% |
| Vasamed, Inc. | 4.67 Million USD | 50.103% |
| Wearable Health Solutions, Inc. | 2.56 Million USD | 8.985% |
| Yubo International Biotech Limited | 1.25 Million USD | -85.363% |